SCHEMBL4817804

SCHEMBL4817804

COc1cc(NC(=O)O)cc(-c2nc(-c3ccccn3)no2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.62
RAB9A P51151 10/20 0.62
PKM P14618 9/20 0.62
SMN1; SMN2 Q16637 9/20 0.62
GRM5 P41594 6/20 0.62
HSP90AA1 P07900 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
MAPT P10636 7/20 0.56
ALDH1A1 P00352 4/20 0.56
TP53 P04637 10/20 0.54
KMT2A Q03164 4/20 0.54
MEN1 O00255 3/20 0.52
TSHR P16473 4/20 0.51
KDM4E B2RXH2 3/20 0.51
HSD17B10 Q99714 3/20 0.51
GAA P10253 1/20 0.51
LMNA P02545 2/20 0.50
KLF5 Q13887 2/20 0.50
HPGD P15428 2/20 0.50
NPSR1 Q6W5P4 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4190985 0.85 PKM (0.67) NPC1RAB9APKMSMN1; SMN2GRM5
SCHEMBL4193244 0.84 NPC1 (0.64) NPC1RAB9APKMSMN1; SMN2GRM5
SCHEMBL4183726 0.84 RAB9A (0.81) NPC1RAB9APKMSMN1; SMN2GRM5
SCHEMBL4197350 0.84 PKM (0.66) NPC1RAB9APKMSMN1; SMN2GRM5
SCHEMBL4181850 0.77 NPC1 (1.00) NPC1RAB9APKMSMN1; SMN2GRM5
SCHEMBL4186215 0.76 GRM5 (0.78) NPC1RAB9APKMSMN1; SMN2GRM5
SCHEMBL4192350 0.75 NPC1 (0.73) NPC1RAB9APKMSMN1; SMN2GRM5
SCHEMBL11709774 0.75 CA2 (0.60) NPC1RAB9APKMSMN1; SMN2GRM5
SCHEMBL4195040 0.74 GRM5 (0.67) NPC1RAB9APKMSMN1; SMN2GRM5
SCHEMBL5223213 0.73 NPC1 (0.57) NPC1RAB9APKMSMN1; SMN2GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896011-A1 NEW USE AstraZeneca AB (SE) 2008-03-12 EP claimed
WO-2007001973-A1 NEW USE ASTRAZENECA AB (SE) 2007-01-04 WO claimed
WO-2005060971-A1 TREATMENT OF REFLUX-RELATED DISEASES ASTRAZENECA AB (SE) 2005-07-07 WO claimed
WO-2005060971-A1 TREATMENT OF REFLUX-RELATED DISEASES ASTRAZENECA AB (SE) 2005-07-07 WO disclosed